Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the <scp>ELN iMDS</scp> flow working group-Reference-Cited by-同舟云学术

Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group

Published:2022-11-23 Issue:1 Volume:104 Page:51-65
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry Part B Clinical

Author:

Kern Wolfgang¹^ORCID,Westers Theresia M.²,Bellos Frauke¹,Bene Marie Christine³^ORCID,Bettelheim Peter⁴,Brodersen Lisa Eidenschink⁵,Burbury Kate⁶,Chu Sung‐Chao⁷,Cullen Matthew⁸,Porta Matteo Della⁹,Dunlop Alan Stewart¹⁰,Johansson Ulrika¹¹,Matarraz Sergio¹²,Oelschlaegel Uta¹³,Ogata Kiyoyuki¹⁴,Porwit Anna¹⁵^ORCID,Preijers Frank¹⁶,Psarra Katherina¹⁷,Saft Leonie¹⁸,Subirá Dolores¹⁹^ORCID,Weiß Elisabeth¹,van der Velden Vincent H. J.²⁰,van de Loosdrecht Arjan²

Affiliation:

1. MLL Munich Leukemia Laboratory Munich Germany

2. Department of Hematology Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam Amsterdam The Netherlands

3. Hematology Biology Nantes University Hospital Nantes France

4. Department of Hematology Elisabethinen Hospital Linz Upper Austria Austria

5. Hematologics, Inc. Seattle Washington USA

6. Peter MacCallum Cancer Centre Melbourne Australia

7. Department of Hematology and Oncology Buddhist Tzu Chi General Hospital Hualien Taiwan

8. Haematological Malignancy Diagnostic Service St James's University Hospital Leeds UK

9. Department of Biomedical Sciences, IRCCS Humanitas Research Hospital Humanitas University Milan Italy

10. Department of Haematology College Hospital London London England

11. Laboratory Medicine University Hospitals Bristol and Weston NHS Foundation Trust Bristol UK

12. Cytometry Service (NUCLEUS), Department of Medicine and IBSAL Cancer Research Center (IBMCC, University of Salamanca‐CSIC), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain

13. Department of Internal Medicine University Hospital of Technical University Dresden Dresden Germany

14. Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan) Tokyo Japan

15. Division of Pathology, Department of Clinical Sciences Lund University Lund Sweden

16. Department of Laboratory Medicine Laboratory of Hematology, Radboudumc Nijmegen The Netherlands

17. Immunology Histocompatibility Department Evangelismos Hospital Athens Greece

18. Clinical Pathology and Cancer Diagnostics Karolinska University Hospital and Institute Stockholm Sweden

19. Department of Medical Immunology Hospital Universitario de Guadalajara Guadalajara Spain

20. Laboratory Medical Immunology, Department of Immunology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22105

Reference42 articles.

1. The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

3. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes

4. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

5. Eastern cooperative oncology group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival;Bennett J. M.;Cancer Research,1981

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes;Pathology and Oncology Research;2024-07-08

2. Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry;Cytometry Part B: Clinical Cytometry;2024-04-24

3. Revisiting the most often used item in the haematological tool box—The extent of haemodilution in bone marrow aspirates;British Journal of Haematology;2024-04-11

4. Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan;British Journal of Haematology;2024-04-08

5. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022;Blood Journal;2023-12-08